RxDoctor Payments Data

Julia Lee, MD

Orthopaedic Surgery · Fresno, CANPI 1437444759

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $282,435 of the $458,019 with a category attached, or 61.7%. Arthrex accounts for 93.8% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $201,727, more than ten times the $5,651 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$458,019in general payments, 2019–2025

Across 689 payments — averaging $664.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$430K
  • Stryker$19K
  • Sequoia Surgical, Inc.$5K
  • Cornerstone Medical Associates, Inc.$3K
  • Shoulder Innovations, Inc.$720
  • Zimmer Biomet$239
  • plus $671 from 9 others
$5,930in research payments, 2019–2025

Across 4 payments — averaging $1482.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$6K
$125,000in ownership & investment interests, 2019–2025

Across 2 payments — averaging $62,500 each. An ownership or investment interest held by the physician or an immediate family member.

  • Lazurite Inc.$125K

What the payments were for

  • Consulting fees$101,30022%
  • Speaking & faculty fees$282,43562%
  • Travel & lodging$47,18810%
  • Food & beverage$16,5384%
  • Education$9,8562%
  • Gifts$7020%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex580$429,648
Stryker(2 entities)50$18,684
Sequoia Surgical, Inc.17$5,398
Cornerstone Medical Associates, Inc.24$2,658
Shoulder Innovations, Inc.3$720
Zimmer Biomet4$239
Smith+Nephew3$209
Steelhead Surgical Inc1$132
Johnson & Johnson1$98
Saxum Surgical, Inc.1$82
Axogen1$55
Bioventus LLC1$31
Pacira Pharmaceuticals Incorporated1$26
Convatec Inc.1$22
Endo Pharmaceuticals Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$458,019 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$500,769
Medicare patients
778
Services billed
9,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$603
Cyclobenzaprine Hcl12$69

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →